Novo Nordisk launches diabetes drug Ozempic in India

Novo Nordisk launched Ozempic, a type 2 diabetes treatment, in India. The injection, available in three dosages, is priced between Rs 8,800 and Rs 11,175 per pen (four weekly doses). Approved in October, Ozempic helps control blood sugar, manage weight, and protect heart/kidneys in diabetic patients.

Leave a Reply

Your email address will not be published. Required fields are marked *